Mobile Health Program for Post-Preeclampsia Hypertension
Multilevel Mobile Health Program to Improve Hypertension Among Midlife Women After Hypertensive Disorder of Pregnancy
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 18 Years and older
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study tests whether home blood pressure checks and online coaching work better than usual care to control high blood pressure. It is for women who now have high blood pressure and had high blood pressure during pregnancy 10–20 years ago.
Strategies targeted to optimize hypertension (HTN) control for midlife women after hypertensive disorders of pregnancy (HDP) have not been studied, despite evidence of a critical need. This proposal targets the 10-20 years postpartum as a key time when women have subclinical cardiovascular (CV) sequelae of uncontrolled HTN and are primed for CV prevention interventions. Before proceeding with large-scale intervention trials of a home blood pressure monitoring (HBPM) and coaching intervention following HDP, further pilot testing is necessary. The overarching hypothesis of this proposal is that a new monitoring and treatment paradigm utilizing HBPM combined with a virtual coaching intervention would be better than standard of care for mid-life women with prior HDP who develop HTN. Women will be assigned in an unblinded manner to the intervention or standard of care control group.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- Women who had high blood pressure during pregnancy or preeclampsia, a pregnancy condition involving high blood pressure.
- The pregnancy condition was diagnosed under medical guidelines when they gave birth at Magee-Womens Hospital between 2008 and 2015.
- It has been 10–20 years since that pregnancy.
- Current blood pressure is 140/90 mmHg or higher, whether or not they take blood pressure medicine.
Who can't join
- A history of heart attack, stroke, heart failure, or narrowed arteries that reduce blood flow to the limbs.
- Men, because this study focuses on pregnancy-related conditions.
- Children, because the study only includes people who gave birth 10–20 years ago.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: * Women who had a history of HDP (either gestational HTN or preeclampsia) diagnosed by ACOG guidelines at the time of delivery at Magee-Womens Hospital between 2008 and 2015, thus 10 to 20 years from their index pregnancy complicated by HDP. * Evidence of current stage 2 HTN (BP ≥ 140/90 mmHg with or without treatment with antihypertensive medication). Exclusion Criteria: * Known clinical CVD (prior myocardial infarction, stroke, heart failure, or peripheral arterial disease). * Males will also be excluded from this study as it focuses on pregnancy related conditions. * Children will be excluded as the study is only recruiting people who are 10-20 years postpartum.
Study sites (1)
PA
- UPMC Magee Womens Hospital · Pittsburgh, PA 15213Amy Travis · Study contact · 4126413295 · travisam@upmc.eduSamantha Bryan · Study contact · myslinskisg@mwri.magee.eduMalamo Countouris, MD, MS · Principal investigatorMore trials in Pittsburgh